Solara Active Pharma Sciences Ltd - 541540 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Devicam Capital LLP & Others Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copies of Newspaper Publication regarding Postal Ballot Notice Solara Active Pharma Sciences Ltd - 541540 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Notice of Postal Ballot Solara Active Pharma Sciences Ltd - 541540 - Change In Senior Management Personnel
Change in Senior Management Personnel Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Change in Directorate
We wish to inform that pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, Board of Directors of the Company vide Circular Resolution dated November 29, 2023 has approved the change in designation of Mr. Rajiv Vijay Nabar from Non-Executive Non-Independent Director to Non-Executive Independent Director of the Company. Solara Active Pharma Sciences Ltd - 541540 - ''Investor Awareness On Online Dispute Resolution Mechanism''.
Investor Awareness on Online Dispute Resolution Mechanism. Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Earnings call Transcript of the call held on November 14, 2023 Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of SEBI (LODR), Regulations, 2015 , please find enclosed herewith copies of newspaper publication. Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 30 and 46 of SEBI (LODR), we hereby confirm that we have uploaded audio recording of the Q2 of FY24 earnings call held on November 14, 2023, on our company website. Solara Active Pharma Sciences Ltd - 541540 - Sale Of Land & Building Of The Wholly Owned Subsidiary Company
We wish to inform that the Board of Directors of the Company at its meeting held today has approved the proposal for sale of Land & Building belonging to Sequent Penems Private Limited (Wholly Owned Subsidiary) of the Company.